Has Petar Igic, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,130 in general payments to Petar Igic, MD across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Petar Igic, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Petar Igic, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Petar Igic, MD

Clinical Cardiac Electrophysiology · Boise, IDNPI 1053365494

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,153 of the $3,130 with a category attached, or 68.8%. Abbott accounts for 72.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $2,202 and has fallen 82.5% since, to $386 in 2025.

$3,130in general payments, 2019–2025

Across 25 payments — averaging $125.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
Biosense Webster, Inc.$484
Medtronic$283
Biotronik Inc.$81
Boston Scientific$24

What the payments were for

Travel & lodging$2,15369%
Food & beverage$97731%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	13	$2,259
Biosense Webster, Inc.	7	$484
Medtronic(2 entities)	3	$283
Biotronik Inc.	1	$81
Boston Scientific	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical cardiac electrophysiology providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$96,035

Medicare patients

1,090

Services billed

2,002

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	31	$42,582
Flecainide Acetate	20	$638
Amiodarone Hcl	30	$517
Metoprolol Succinate	21	$482
Dofetilide	13	$330

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Boise

Marcos DaccarettBoise$154K
Daniel NoonanBoise$95K
Luciano AmadoBoise$77K
Justice OranefoBoise$30K
Joshua MozesBoise$26K
Adam GrimaldiBoise$25K
Melinda MarksBoise$9K
Mark RichardsPocatello$198K
Janet OttoIdaho Falls$21K
Michele Murphy CookCoeur D Alene$14K

See the full list for Idaho →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →